Cargando…

L1000CDS(2): LINCS L1000 characteristic direction signatures search engine

The library of integrated network-based cellular signatures (LINCS) L1000 data set currently comprises of over a million gene expression profiles of chemically perturbed human cell lines. Through unique several intrinsic and extrinsic benchmarking schemes, we demonstrate that processing the L1000 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Qiaonan, Reid, St Patrick, Clark, Neil R, Wang, Zichen, Fernandez, Nicolas F, Rouillard, Andrew D, Readhead, Ben, Tritsch, Sarah R, Hodos, Rachel, Hafner, Marc, Niepel, Mario, Sorger, Peter K, Dudley, Joel T, Bavari, Sina, Panchal, Rekha G, Ma’ayan, Avi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389891/
https://www.ncbi.nlm.nih.gov/pubmed/28413689
http://dx.doi.org/10.1038/npjsba.2016.15
_version_ 1782521356733120512
author Duan, Qiaonan
Reid, St Patrick
Clark, Neil R
Wang, Zichen
Fernandez, Nicolas F
Rouillard, Andrew D
Readhead, Ben
Tritsch, Sarah R
Hodos, Rachel
Hafner, Marc
Niepel, Mario
Sorger, Peter K
Dudley, Joel T
Bavari, Sina
Panchal, Rekha G
Ma’ayan, Avi
author_facet Duan, Qiaonan
Reid, St Patrick
Clark, Neil R
Wang, Zichen
Fernandez, Nicolas F
Rouillard, Andrew D
Readhead, Ben
Tritsch, Sarah R
Hodos, Rachel
Hafner, Marc
Niepel, Mario
Sorger, Peter K
Dudley, Joel T
Bavari, Sina
Panchal, Rekha G
Ma’ayan, Avi
author_sort Duan, Qiaonan
collection PubMed
description The library of integrated network-based cellular signatures (LINCS) L1000 data set currently comprises of over a million gene expression profiles of chemically perturbed human cell lines. Through unique several intrinsic and extrinsic benchmarking schemes, we demonstrate that processing the L1000 data with the characteristic direction (CD) method significantly improves signal to noise compared with the MODZ method currently used to compute L1000 signatures. The CD processed L1000 signatures are served through a state-of-the-art web-based search engine application called L1000CDS(2). The L1000CDS(2) search engine provides prioritization of thousands of small-molecule signatures, and their pairwise combinations, predicted to either mimic or reverse an input gene expression signature using two methods. The L1000CDS(2) search engine also predicts drug targets for all the small molecules profiled by the L1000 assay that we processed. Targets are predicted by computing the cosine similarity between the L1000 small-molecule signatures and a large collection of signatures extracted from the gene expression omnibus (GEO) for single-gene perturbations in mammalian cells. We applied L1000CDS(2) to prioritize small molecules that are predicted to reverse expression in 670 disease signatures also extracted from GEO, and prioritized small molecules that can mimic expression of 22 endogenous ligand signatures profiled by the L1000 assay. As a case study, to further demonstrate the utility of L1000CDS(2), we collected expression signatures from human cells infected with Ebola virus at 30, 60 and 120 min. Querying these signatures with L1000CDS(2) we identified kenpaullone, a GSK3B/CDK2 inhibitor that we show, in subsequent experiments, has a dose-dependent efficacy in inhibiting Ebola infection in vitro without causing cellular toxicity in human cell lines. In summary, the L1000CDS(2) tool can be applied in many biological and biomedical settings, while improving the extraction of knowledge from the LINCS L1000 resource.
format Online
Article
Text
id pubmed-5389891
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53898912017-04-12 L1000CDS(2): LINCS L1000 characteristic direction signatures search engine Duan, Qiaonan Reid, St Patrick Clark, Neil R Wang, Zichen Fernandez, Nicolas F Rouillard, Andrew D Readhead, Ben Tritsch, Sarah R Hodos, Rachel Hafner, Marc Niepel, Mario Sorger, Peter K Dudley, Joel T Bavari, Sina Panchal, Rekha G Ma’ayan, Avi NPJ Syst Biol Appl Article The library of integrated network-based cellular signatures (LINCS) L1000 data set currently comprises of over a million gene expression profiles of chemically perturbed human cell lines. Through unique several intrinsic and extrinsic benchmarking schemes, we demonstrate that processing the L1000 data with the characteristic direction (CD) method significantly improves signal to noise compared with the MODZ method currently used to compute L1000 signatures. The CD processed L1000 signatures are served through a state-of-the-art web-based search engine application called L1000CDS(2). The L1000CDS(2) search engine provides prioritization of thousands of small-molecule signatures, and their pairwise combinations, predicted to either mimic or reverse an input gene expression signature using two methods. The L1000CDS(2) search engine also predicts drug targets for all the small molecules profiled by the L1000 assay that we processed. Targets are predicted by computing the cosine similarity between the L1000 small-molecule signatures and a large collection of signatures extracted from the gene expression omnibus (GEO) for single-gene perturbations in mammalian cells. We applied L1000CDS(2) to prioritize small molecules that are predicted to reverse expression in 670 disease signatures also extracted from GEO, and prioritized small molecules that can mimic expression of 22 endogenous ligand signatures profiled by the L1000 assay. As a case study, to further demonstrate the utility of L1000CDS(2), we collected expression signatures from human cells infected with Ebola virus at 30, 60 and 120 min. Querying these signatures with L1000CDS(2) we identified kenpaullone, a GSK3B/CDK2 inhibitor that we show, in subsequent experiments, has a dose-dependent efficacy in inhibiting Ebola infection in vitro without causing cellular toxicity in human cell lines. In summary, the L1000CDS(2) tool can be applied in many biological and biomedical settings, while improving the extraction of knowledge from the LINCS L1000 resource. Nature Publishing Group 2016-08-04 /pmc/articles/PMC5389891/ /pubmed/28413689 http://dx.doi.org/10.1038/npjsba.2016.15 Text en Copyright © 2016 Published in partnership with the Systems Biology Institute http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Article
Duan, Qiaonan
Reid, St Patrick
Clark, Neil R
Wang, Zichen
Fernandez, Nicolas F
Rouillard, Andrew D
Readhead, Ben
Tritsch, Sarah R
Hodos, Rachel
Hafner, Marc
Niepel, Mario
Sorger, Peter K
Dudley, Joel T
Bavari, Sina
Panchal, Rekha G
Ma’ayan, Avi
L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
title L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
title_full L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
title_fullStr L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
title_full_unstemmed L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
title_short L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
title_sort l1000cds(2): lincs l1000 characteristic direction signatures search engine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389891/
https://www.ncbi.nlm.nih.gov/pubmed/28413689
http://dx.doi.org/10.1038/npjsba.2016.15
work_keys_str_mv AT duanqiaonan l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT reidstpatrick l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT clarkneilr l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT wangzichen l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT fernandeznicolasf l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT rouillardandrewd l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT readheadben l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT tritschsarahr l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT hodosrachel l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT hafnermarc l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT niepelmario l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT sorgerpeterk l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT dudleyjoelt l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT bavarisina l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT panchalrekhag l1000cds2lincsl1000characteristicdirectionsignaturessearchengine
AT maayanavi l1000cds2lincsl1000characteristicdirectionsignaturessearchengine